Q1 2018

Filed Jul 25, 2018 · 10-Q · 25 days after period end · 0001740797-18-000012

Q1 2018 · 10-Q

Revenue—

Net Income

-$6.20K

no prior Q1 2017 on file

EPS Diluted

$0.00

no prior Q1 2017 on file

Gross Profit$0—

Operating Cash Flow-$5,596—

Same quarter

no prior Q1 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2018 · filed Jul 25, 2018 · 25 d after period end

Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR